Back to Search
Start Over
Circ_CHFR Promotes Platelet-Derived Growth Factor-BB-Induced Proliferation, Invasion, and Migration in Vascular Smooth Muscle Cells via the miR-149-5p/NRP2 Axis.
- Source :
-
Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2022 Jan 01; Vol. 79 (1), pp. e94-e102. - Publication Year :
- 2022
-
Abstract
- Abstract: Circular RNA checkpoint with forkhead and ring finger domains (circ&#95;CHFR) were reported to regulate vascular smooth muscle cell (VSMC) dysfunction during atherosclerosis (AS). However, the molecule mechanism of circ&#95;CHFR in AS remains largely unclear. Human VSMCs (HVSMCs) were exposed to platelet-derived growth factor-BB (PDGF-BB) in vitro. Levels of circ&#95;CHFR, microRNA (miR)-149-5p, and neuropilin 2 (NRP2) were determined using quantitative real-time polymerase chain reaction and western blot. Cell proliferation, migration, and invasion were analyzed using cell counting kit-8, colony formation, flow cytometry, wound healing, and transwell assays. The binding interaction between miR-149-5p and circ&#95;CHFR or NRP2 was investigated using the dual-luciferase reporter and RNA immunoprecipitation assays. Circ&#95;CHFR was elevated in PDGF-BB-induced HVSMCs in a dose-independent manner. Silencing of circ&#95;CHFR reversed PDGF-BB-evoked promotion of cell proliferation, migration and invasion, as well as suppression of cell apoptosis in HVSMCs. Mechanistically, circ&#95;CHFR directly bound to miR-149-5p, and miR-149-5p inhibition attenuated the effects of circ&#95;CHFR knockdown on PDGF-BB-induced HVSMCs. Besides, NRP2 was confirmed to be a target of miR-149-5p, and circ&#95;CHFR could regulate NRP2 expression through sponging miR-149-5p. Moreover, miR-149-5p overexpression abolished PDGF-BB-triggered enhancement of cell proliferation, migration, and invasion by targeting NRP2. Circ&#95;CHFR promoted the proliferation, invasion, and migration of PDGF-BB-induced HVSMCs through miR-149-5p/NRP2 axis, providing a new insight into the pathogenesis of AS and a potential therapeutic target for AS treatment.<br />Competing Interests: The authors declare that they have no conflicts of interest.<br /> (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Subjects :
- Atherosclerosis genetics
Atherosclerosis pathology
Cells, Cultured
Gene Expression Regulation
Humans
MicroRNAs genetics
Muscle, Smooth, Vascular metabolism
Muscle, Smooth, Vascular pathology
Myocytes, Smooth Muscle metabolism
Myocytes, Smooth Muscle pathology
Neuropilin-2 genetics
RNA, Circular genetics
Signal Transduction
Atherosclerosis metabolism
Becaplermin pharmacology
Cell Movement drug effects
Cell Proliferation drug effects
MicroRNAs metabolism
Muscle, Smooth, Vascular drug effects
Myocytes, Smooth Muscle drug effects
Neuropilin-2 metabolism
RNA, Circular metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1533-4023
- Volume :
- 79
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of cardiovascular pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 33990513
- Full Text :
- https://doi.org/10.1097/FJC.0000000000001055